The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
As of close of business last night, Rallybio Corp’s stock clocked out at $0.58, up 3.59% from its previous closing price of $0.56. In other words, the price has increased by $3.59 from its previous closing price. On the day, 1.8 million shares were traded. RLYB stock price reached its highest trading level at $0.61 during the session, while it also had its lowest trading level at $0.5408.
Ratios:
To gain a deeper understanding of RLYB’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.98 and its Current Ratio is at 9.98. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Jefferies Downgraded its Buy to Hold on February 07, 2024, whereas the target price for the stock was revised from $7 to $1.50.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLYB now has a Market Capitalization of 24131704 and an Enterprise Value of -21559312. For the stock, the TTM Price-to-Sale (P/S) ratio is 31.76 while its Price-to-Book (P/B) ratio in mrq is 0.52. Its current Enterprise Value per Revenue stands at -28.33 whereas that against EBITDA is 0.518.
Stock Price History:
The Beta on a monthly basis for RLYB is -1.10, which has changed by -0.47927928 over the last 52 weeks, in comparison to a change of 0.1716845 over the same period for the S&P500. Over the past 52 weeks, RLYB has reached a high of $1.24, while it has fallen to a 52-week low of $0.22. The 50-Day Moving Average of the stock is 18.83%, while the 200-Day Moving Average is calculated to be -7.23%.
Shares Statistics:
It appears that RLYB traded 2.92M shares on average per day over the past three months and 424950 shares per day over the past ten days. A total of 41.71M shares are outstanding, with a floating share count of 20.56M. Insiders hold about 50.80% of the company’s shares, while institutions hold 28.48% stake in the company. Shares short for RLYB as of 1755216000 were 771851 with a Short Ratio of 0.26, compared to 1752537600 on 1975093. Therefore, it implies a Short% of Shares Outstanding of 771851 and a Short% of Float of 2.27.
Earnings Estimates
A detailed examination of Rallybio Corp (RLYB) is currently in progress, with 2.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$0.2, with high estimates of -$0.17 and low estimates of -$0.23.
Analysts are recommending an EPS of between -$0.77 and -$0.88 for the fiscal current year, implying an average EPS of -$0.82. EPS for the following year is -$1.16, with 3.0 analysts recommending between -$0.64 and -$2.03.
Revenue Estimates
A total of 3 analysts have provided revenue estimates for RLYB’s current fiscal year. The highest revenue estimate was $800k, while the lowest revenue estimate was $400k, resulting in an average revenue estimate of $533.33k. In the same quarter a year ago, actual revenue was $636k
